MedPath

Trauma-informed Intervention to Reduce Substance Use and to Support Community Transition

Not Applicable
Not yet recruiting
Conditions
Substance Use Disorder (SUD)
Registration Number
NCT06651528
Lead Sponsor
Michele Staton
Brief Summary

The overall aim of this study is to reduce overdose risk for criminal legal system (CLS) involved women during community re-entry through the adaptation and testing of an innovative, trauma-informed, relational intervention approach (Trust-Based Relational Intervention or TBRI).

Detailed Description

R61 Phase (Intervention adaptation): The TBRI intervention will be strategically adapted for CLS-involved women during the R61 to achieve 2 specific aims: 1) Adapt TBRI by focusing on adapting two intervention components - prison group sessions and re-entry recovery support - using focus groups with key stakeholders (N=30) including administrators, practitioners, and women with "lived experience," and target alignment with the unique treatment needs of the women and establish intervention approach feasibility; and 2) Pilot test the adapted intervention components in one group of women (n=8) at the KCIW facility. Final adaptations will be made to the TRUST manual for the R33 implementation.

R33 Phase (Intervention testing): The R33 will test the effectiveness of the adapted TBRI-WRA to reduce overdose risk in the community following prison release, while also collecting data on key constructs hypothesized to influence successful intervention implementation. The primary aim of the R33 is to examine effectiveness of the adapted TBRI Women's Re-entry Approach (TBRI-WRA) in reducing overdose risk among women (N=264) in four sites following release from prison-based SUD treatment. Study conditions include (1) Treatment as Usual (TAU, standard in-prison SUD treatment, n=88), (2) In-prison TBRI (TAU + TBRI prison-based sessions only; n=88), and (3) TBRI + Re-entry Recovery Support (TAU + prison-based TBRI sessions + Re-entry Recovery Support; n=88). The R33 will also examine implementation factors associated with study preparation, launch, sustainability, and scalability.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
264
Inclusion Criteria
  • participating in prison-based SUD treatment program
  • have a release date within 3 months
  • self-identified history of violent victimization
  • have no indication of current suicidal risk,
  • able to identify one "Safe Support Person" (SSP) in the community who can be trusted to support recovery and is willing to be contacted about participation
Exclusion Criteria
  • release date greater than 3 months
  • no self-identified history of violent victimization
  • indication of current suicidal risk
  • unable to identify one "Safe Support Person" (SSP) in the community who can be trusted to support recovery and is willing to be contacted about participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in overdose riskBaseline and at 3 and 6 months post-release from prison

Change in number of days of any substance from baseline to post-release using self-report data

Secondary Outcome Measures
NameTimeMethod
Change in trauma-related symptomsBaseline and at 3 and 6 months post-release from prison

Change in number of trauma-related symptoms associated with violence

Trial Locations

Locations (4)

Western Kentucky Correctional Complex

🇺🇸

Fredonia, Kentucky, United States

Kentucky Correctional Institution for Women

🇺🇸

Pewee Valley, Kentucky, United States

Chillicothe Correctional Center

🇺🇸

Chillicothe, Missouri, United States

Women's Eastern Reception, Diagnostic and Correctional Center

🇺🇸

Vandalia, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath